Multivessel vs. culprit-lesion only percutaneous coronary intervention in ST-elevation myocardial infarction
Hans-Josef Feistritzer1, Alexander Jobs2, Steffen Desch2
1Department of Internal Medicine/Cardiology, Heart Center Leipzig at University of Leipzig, Strümpellstr. 39, 04289, Leipzig, Germany. Hans-Josef.Feistritzer@medizin.uni-leipzig.de.
Insights
Complete revascularization in ST-elevation myocardial infarction (STEMI) patients reduces cardiovascular death and heart attacks. This review examines evidence for optimal treatment of non-infarct arteries in STEMI care.
Area of Science:
- Cardiology
- Interventional Cardiology
- Clinical Trials
Background:
- The optimal management of non-infarct-related coronary arteries in ST-elevation myocardial infarction (STEMI) patients remains a long-standing debate.
- Previous trials suggested benefits of multivessel percutaneous coronary intervention (PCI) mainly by reducing revascularization rates.
Purpose of the Study:
- To review current evidence on revascularization strategies for patients with STEMI.
- To evaluate the impact of complete revascularization versus culprit-lesion-only PCI.
Main Methods:
- Systematic review of randomized controlled trials and relevant clinical studies.
- Analysis of data from recent large-scale trials like the COMPLETE trial.
Main Results:
- The COMPLETE trial demonstrated a significant reduction in the composite endpoint of cardiovascular mortality and myocardial infarction with complete revascularization.
- Earlier trials indicated benefits of multivessel PCI, primarily through decreased need for repeat procedures.
Conclusions:
- Complete revascularization appears to be a beneficial strategy in STEMI patients, reducing major adverse cardiovascular events.
- Further evidence supports a comprehensive approach to managing all significant coronary lesions in STEMI.
Abstract:
The optimal treatment of non-infarct-related coronary arteries in patients presenting with ST-elevation myocardial infarction (STEMI) has been a subject of debate for many years. Earlier medium-sized randomized controlled trials reported a benefit of multivessel percutaneous coronary intervention (PCI) primarily due to a reduction of subsequent revascularizations. Recently, the well-powered COMPLETE trial showed a reduction in the composite endpoint of cardiovascular mortality and myocardial reinfarction through complete revascularization. The present review summarizes the current evidence regarding revascularization strategies in STEMI patients.
Related Concept Videos
Acute Coronary Syndrome I: Introduction
Acute Coronary Syndrome III: Diagnostic Studies
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations
Cardiac Catheterization I: Pre-Procedure Overview


